Please login to the form below

Not currently logged in
Email:
Password:

Quillivant XR

This page shows the latest Quillivant XR news and features for those working in and with pharma, biotech and healthcare.

Pfizer enters ADHD market with Quillivant XR launch

Pfizer enters ADHD market with Quillivant XR launch

The efficacy of Quillivant XR was evaluated in a randomized, double-blind, placebo-controlled, crossover, multicentre, laboratory classroom study of 45 children with ADHD. ... Quillivant XR has a child-friendly formulation that provides an extended

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2012 Pharma deals during October 2012

    Established products – new formulations. Pfizer's acquisition of NextWave Pharmaceuticals bolsters its established products business unit bringing Quillivant XR (methylphenidate hydrochloride), which recently secured FDA approval for attention

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics